A Phase Ib Study of Single Agent Idelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

A Phase Ib Study of Single Agent Idelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Oncologist. 2020 Apr 30;: Authors: Borazanci E, Pishvaian MJ, Weekes C, Huang J, Rajakumaraswamy N PMID: 32356383 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32356383?dopt=Abstract

Source: The Oncologist - April 29, 2020 Category: Cancer & Oncology Authors: Borazanci E, Pishvaian MJ, Weekes C, Huang J, Rajakumaraswamy N Tags: Oncologist Source Type: research

More News: Adenocarcinoma | Cancer & Oncology | Chemotherapy | Pancreas | Study